CIK 0001781174 · <br>Emerging growth company
Acrivon Therapeutics, Inc.
Sign in to watch- Ticker
- ACRV
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 825125532
- Phone
- 617-207-8979
- Business address
- 480 ARSENAL WAY, SUITE 100, WATERTOWN, MA, 02472
- 4 Grant or award Director acquired 9,366 shares (grant or award)
- 4 Grant or award Director acquired 9,366 shares (grant or award)
- 4 Grant or award Director acquired 9,366 shares (grant or award)
- 4 Grant or award Director acquired 9,366 shares (grant or award)
- 4 Grant or award Director acquired 9,366 shares (grant or award)
- 4 Grant or award Director acquired 9,366 shares (grant or award)
- 4 Grant or award Director acquired 9,366 shares (grant or award)
- 4 Grant or award Chief Accounting Officer acquired 14,227 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 38,817 shares (grant or award)
- 4 Grant or award Chief Legal Officer acquired 49,830 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 46,167 shares (grant or award)
- 4 Grant or award Chief Development Officer acquired 38,584 shares (grant or award)
- 4 Grant or award Chief Operating Officer acquired 72,981 shares (grant or award)
- 4 Grant or award President and CEO acquired 252,801 shares (grant or award)
- 4 Shares withheld for taxes Chief Accounting Officer gave up 99 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Legal Officer gave up 184 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Development Officer gave up 404 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Operating Officer gave up 613 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 1,743 shares (to pay taxes)
- 4 Grant or award Director acquired 3,888,888 shares (grant or award)
Page 2 of 11 · 206 filings